{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:39:00Z","timestamp":1792291140748,"version":"4.4.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Addict Sci Clin Pract"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Patients with recurrent acute flares of pancreatitis\u2014especially those receiving frequent opioid treatment for pain\u2014can develop physiologic dependence to opioids. This can complicate the clinical picture, making it difficult to distinguish between true pancreatitis flares and opioid withdrawal presenting with similar symptoms. We describe two cases of patients admitted recurrently for pancreatitis: a 24-year-old Haitian male with alcohol use disorder, and a 37-year-old Indian female with hypertriglyceridemia. Both developed iatrogenic physiologic opioid dependence after frequent hospitalizations and opioid prescriptions. Both patients stabilized after initiation of buprenorphine, remaining in care and hospitalization-free for over a year. These cases illustrate the importance of identifying and treating the underlying etiology of abdominal pain, judiciously prescribing opioids to treat pancreatitis flares, and having a low threshold for considering iatrogenic physiologic opioid dependence in patients evaluated for recurrent pancreatitis. They also highlight the potential role that buprenorphine can play to mitigate recurrent admissions by providing safer pain control and treatment for physiologic opioid dependence.<\/jats:p>","DOI":"10.1186\/s13722-026-00653-7","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T11:08:36Z","timestamp":1770894516000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Iatrogenic physiologic opioid dependence masquerading as recurrent acute pancreatitis flares: case series"],"prefix":"10.1186","volume":"21","author":[{"given":"David","family":"Dayan-Rosenman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Diletti-Swenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha","family":"Ghayalod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randi","family":"Sokol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"issue":"4","key":"653_CR1","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1053\/j.gastro.2009.02.038","volume":"136","author":"JE Everhart","year":"2009","unstructured":"Everhart JE, Ruhl CE. Burden of digestive diseases in the united States part III: Liver, biliary Tract, and pancreas. Gastroenterology. 2009;136(4):1134\u201344. https:\/\/doi.org\/10.1053\/j.gastro.2009.02.038.","journal-title":"Gastroenterology"},{"key":"653_CR2","doi-asserted-by":"publisher","unstructured":"Mullady DK, Yadav D, Amann ST, et al. Type of pain, pain-associated complications, quality of life, disability and resource utilisation in chronic pancreatitis: a prospective cohort study. Published Online January. 2011;1. https:\/\/doi.org\/10.1136\/gut.2010.213835.","DOI":"10.1136\/gut.2010.213835"},{"issue":"3","key":"653_CR3","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/S0016-5085(98)70157-X","volume":"115","author":"AL Warshaw","year":"1998","unstructured":"Warshaw AL, Banks PA, Fern\u00e0ndez\u2013del Castillo C. AGA technical review: treatment of pain in chronic pancreatitis. Gastroenterology. 1998;115(3):765\u201376. https:\/\/doi.org\/10.1016\/S0016-5085(98)70157-X.","journal-title":"Gastroenterology"},{"issue":"23","key":"653_CR4","doi-asserted-by":"publisher","first-page":"3142","DOI":"10.3748\/wjg.v27.i23.3142","volume":"27","author":"I Shah","year":"2021","unstructured":"Shah I, Sheth SG, Kothari DJ. Pain management in chronic pancreatitis incorporating safe opioid practices: challenge accepted. World J Gastroenterol. 2021;27(23):3142\u20137. https:\/\/doi.org\/10.3748\/wjg.v27.i23.3142.","journal-title":"World J Gastroenterol"},{"issue":"12","key":"653_CR5","doi-asserted-by":"publisher","first-page":"5493","DOI":"10.1007\/s10620-022-07459-y","volume":"67","author":"I Shah","year":"2022","unstructured":"Shah I, Bocchino R, Yakah W, et al. Evaluating outcomes and misuse in Opioid-Dependent chronic pancreatitis using a State-Mandated monitoring system. Dig Dis Sci. 2022;67(12):5493\u20139. https:\/\/doi.org\/10.1007\/s10620-022-07459-y.","journal-title":"Dig Dis Sci"},{"key":"653_CR6","doi-asserted-by":"publisher","DOI":"10.20524\/aog.2021.0579","author":"A Adejumo","year":"2021","unstructured":"Adejumo A. Predictors, rates, and trends of opioid use disorder among patients hospitalized with chronic pancreatitis. Ann Gastroenterol Published Online. 2021. https:\/\/doi.org\/10.20524\/aog.2021.0579.","journal-title":"Ann Gastroenterol Published Online"},{"issue":"6","key":"653_CR7","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/S2215-0366(23)00095-0","volume":"10","author":"L Degenhardt","year":"2023","unstructured":"Degenhardt L, Clark B, Macpherson G, et al. Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies. Lancet Psychiatry. 2023;10(6):386\u2013402. https:\/\/doi.org\/10.1016\/S2215-0366(23)00095-0.","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"653_CR8","doi-asserted-by":"publisher","first-page":"CD002209","DOI":"10.1002\/14651858.CD002209.pub2","volume":"2009","author":"RP Mattick","year":"2009","unstructured":"Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2009;2009(3):CD002209. https:\/\/doi.org\/10.1002\/14651858.CD002209.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"653_CR9","doi-asserted-by":"publisher","first-page":"j1550","DOI":"10.1136\/bmj.j1550","volume":"26","author":"L Sordo","year":"2017","unstructured":"Sordo L, Barrio G, Bravo MJ, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ Published Online April. 2017;26:j1550. https:\/\/doi.org\/10.1136\/bmj.j1550.","journal-title":"BMJ Published Online April"},{"issue":"3","key":"653_CR10","doi-asserted-by":"publisher","first-page":"388","DOI":"10.7326\/M22-2917","volume":"176","author":"F Sandbrink","year":"2023","unstructured":"Sandbrink F, Murphy JL, Johansson M, et al. The use of opioids in the management of chronic pain: synopsis of the 2022 updated U.S. Department of veterans affairs and U.S. Department of defense clinical practice guideline. Ann Intern Med. 2023;176(3):388\u201397. https:\/\/doi.org\/10.7326\/M22-2917.","journal-title":"Ann Intern Med"},{"key":"653_CR11","unstructured":"VA Pharmacy Benefits Management Services and the National Formulary Committee in collaboration with, the VHA National office of Pain Management, Opioid Safety and PDMP (PMOP). Buprenorphine for the management of chronic pain: national guidance document. March; 2024."},{"key":"653_CR12","unstructured":"Pain Management Best Practices Inter-Agency Task Force. U.S. Department of Health and Human Services. May). Pain management best practices: Inter-agency task force report\u2014updates, gaps, inconsistencies, and recommendations; 2019."},{"issue":"2S","key":"653_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/ADM.0000000000000633","volume":"14","author":"The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder","year":"2020","unstructured":"The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder. 2020 focused update. J Addict Med. 2020;14(2S):1\u201391. https:\/\/doi.org\/10.1097\/ADM.0000000000000633.","journal-title":"J Addict Med"},{"key":"653_CR14","doi-asserted-by":"publisher","unstructured":"Kaski S, Marshalek P, Herschler J, et al. Sublingual buprenorphine\/naloxone and multi-modal management for high-risk chronic pain patients. J Clin Med. 2021;10(5). https:\/\/doi.org\/10.3390\/jcm10050973.","DOI":"10.3390\/jcm10050973"},{"issue":"4","key":"653_CR15","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1093\/pm\/pnz356","volume":"21","author":"L Webster","year":"2020","unstructured":"Webster L, Gudin J, Raffa RB, et al. Understanding buprenorphine for use in chronic pain: expert opinion. Pain Med Off J Am Acad Pain Med. 2020;21(4):714\u201323. https:\/\/doi.org\/10.1093\/pm\/pnz356.","journal-title":"Pain Med Off J Am Acad Pain Med"},{"issue":"8","key":"653_CR16","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1097\/00001888-200308000-00003","volume":"78","author":"P Croskerry","year":"2003","unstructured":"Croskerry P. The importance of cognitive errors in diagnosis and strategies to minimize them. Acad Med. 2003;78(8):775\u201380.","journal-title":"Acad Med"},{"key":"653_CR17","doi-asserted-by":"publisher","unstructured":"Tversky A, Kahneman D. Judgment under uncertainty: heuristics and biases. Defense Technical Information Center; 1973. https:\/\/doi.org\/10.21236\/AD0767426.","DOI":"10.21236\/AD0767426"},{"issue":"1","key":"653_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.gastha.2021.09.006","volume":"1","author":"AD Nelson","year":"2022","unstructured":"Nelson AD, Lugo-Fagundo NS, Mahapatra SJ, et al. A systematic review and Meta-analysis of opioids vs nonopioids in acute pancreatitis. Gastro Hep Adv. 2022;1(1):83\u201392. https:\/\/doi.org\/10.1016\/j.gastha.2021.09.006.","journal-title":"Gastro Hep Adv"},{"key":"653_CR19","doi-asserted-by":"publisher","unstructured":"Cai W, Liu F, Wen Y, et al. Pain management in acute pancreatitis: a systematic review and meta-analysis of randomised controlled trials. Front Med (Lausanne). 2021;8. https:\/\/doi.org\/10.3389\/fmed.2021.782151.","DOI":"10.3389\/fmed.2021.782151"},{"issue":"4","key":"653_CR20","doi-asserted-by":"publisher","first-page":"281","DOI":"10.5455\/medarh.2023.77.281-287","volume":"77","author":"M Almulhim","year":"2023","unstructured":"Almulhim M, Almulihi Q, Almumtin H, Alghanim M, AlAbdulbaqi D, Almulihi F. The efficacy and safety of using opioids in acute pancreatitis: an update on systematic review and Meta-Analysis. Med Arch. 2023;77(4):281. https:\/\/doi.org\/10.5455\/medarh.2023.77.281-287.","journal-title":"Med Arch"},{"issue":"1","key":"653_CR21","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1136\/gutjnl-2012-302779","volume":"62","author":"PA Banks","year":"2013","unstructured":"Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis\u20142012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1):102\u201311. https:\/\/doi.org\/10.1136\/gutjnl-2012-302779.","journal-title":"Gut"},{"issue":"5","key":"653_CR22","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.pan.2014.08.001","volume":"14","author":"JH Choi","year":"2014","unstructured":"Choi JH, Kim MH, Oh D, et al. Clinical relevance of the revised Atlanta classification focusing on severity stratification system. Pancreatology. 2014;14(5):324\u20139. https:\/\/doi.org\/10.1016\/j.pan.2014.08.001.","journal-title":"Pancreatology"},{"issue":"2","key":"653_CR23","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1080\/02791072.2003.10400007","volume":"35","author":"DR Wesson","year":"2003","unstructured":"Wesson DR, Ling W. The clinical opiate withdrawal scale (COWS). J Psychoact Drugs. 2003;35(2):253\u20139. https:\/\/doi.org\/10.1080\/02791072.2003.10400007.","journal-title":"J Psychoact Drugs"},{"issue":"4","key":"653_CR24","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1001\/jama.2020.20317","volume":"325","author":"MA Mederos","year":"2021","unstructured":"Mederos MA, Reber HA, Girgis MD, Acute Pancreatitis. Rev JAMA. 2021;325(4):382. https:\/\/doi.org\/10.1001\/jama.2020.20317.","journal-title":"Rev JAMA"},{"key":"653_CR25","unstructured":"Quinlan JD. Acute pancreatitis. Acute Pancreat."},{"issue":"4","key":"653_CR26","doi-asserted-by":"publisher","first-page":"395","DOI":"10.2174\/1570159043359477","volume":"2","author":"K Lutfy","year":"2004","unstructured":"Lutfy K, Cowan A. Buprenorphine: a unique drug with complex Pharmacology. Curr Neuropharmacol. 2004;2(4):395\u2013402. https:\/\/doi.org\/10.2174\/1570159043359477.","journal-title":"Curr Neuropharmacol"},{"issue":"1","key":"653_CR27","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s40122-019-00143-6","volume":"9","author":"J Gudin","year":"2020","unstructured":"Gudin J, Fudin JA, Narrative Pharmacological. Review of buprenorphine: A unique opioid for the treatment of chronic pain. Pain Ther. 2020;9(1):41\u201354. https:\/\/doi.org\/10.1007\/s40122-019-00143-6.","journal-title":"Pain Ther"}],"container-title":["Addiction Science &amp; Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13722-026-00653-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-026-00653-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-026-00653-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:10:17Z","timestamp":1781633417000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13722-026-00653-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["653"],"URL":"https:\/\/doi.org\/10.1186\/s13722-026-00653-7","relation":{},"ISSN":["1940-0640"],"issn-type":[{"value":"1940-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"18 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Per the Cambridge Health Alliance\u2019s institutional review board (IRB), for case reports with 3 or fewer patients, this project does not meet the federal definition of research and hence did not need IRB review (correspondence on 4\/23\/2025). However, they did recommend patient authorization (see below).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"We obtained written consent for publication from both patients included in this manuscript. These signed consent forms are available upon request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26"}}